Predictors of reoperation for spinal disorders in Chiari malformation patients with prior surgical decompression
Author:
Onafowokan Oluwatobi O.1, Das Ankita1, Mir Jamshaid M.1, Alas Haddy1, Williamson Tyler K.1, Mcfarland Kimberly1, Varghese Jeffrey2, Naessig Sara1, Imbo Bailey1, Passfall Lara1, Krol Oscar1, Tretiakov Peter1, Joujon-Roche Rachel1, Dave Pooja1, Moattari Kevin1, Owusu-Sarpong Stephane1, Lebovic Jordan1, Vira Shaleen3, Diebo Bassel4, Lafage Virginie5, Passias Peter Gust1
Affiliation:
1. Department of Orthopedic and Neurological Surgery, NYU Langone Orthopaedic Hospital, New York, USA 2. Twin Cities Spine Centre, Minneapolis, MN, USA 3. Department of Orthopedic Surgery, Banner Health, Phoenix, AZ, USA 4. Department of Orthopedic Surgery, Warren Alpert School of Medicine, Brown University, RI, USA 5. Department of Orthopaedics, Lenox Hill Hospital, Northwell Health, New York, USA
Abstract
Background:
Chiari malformation (CM) is a cluster of related developmental anomalies of the posterior fossa ranging from asymptomatic to fatal. Cranial and spinal decompression can help alleviate symptoms of increased cerebrospinal fluid pressure and correct spinal deformity. As surgical intervention for CM increases in frequency, understanding predictors of reoperation may help optimize neurosurgical planning.
Materials and Methods:
This was a retrospective analysis of the prospectively collected Healthcare Cost and Utilization Project’s California State Inpatient Database years 2004–2011. Chiari malformation Types 1–4 (queried with ICD-9 CM codes) with associated spinal pathologies undergoing stand-alone spinal decompression (queried with ICD-9 CM procedure codes) were included. Cranial decompressions were excluded.
Results:
One thousand four hundred and forty-six patients (29.28 years, 55.6% of females) were included. Fifty-eight patients (4.01%) required reoperation (67 reoperations). Patients aged 40–50 years had the most reoperations (11); however, patients aged 15–20 years had a significantly higher reoperation rate than all other groups (15.5% vs. 8.2%, P = 0.048). Female gender was significantly associated with reoperation (67.2% vs. 55.6%, P = 0.006). Medical comorbidities associated with reoperation included chronic lung disease (19% vs. 6.9%, P < 0.001), iron deficiency anemia (10.3% vs. 4.1%, P = 0.024), and renal failure (3.4% vs. 0.9%, P = 0.05). Associated significant cluster anomalies included spina bifida (48.3% vs. 34.8%, P = 0.035), tethered cord syndrome (6.9% vs. 2.1%, P = 0.015), syringomyelia (12.1% vs. 5.9%, P = 0.054), hydrocephalus (37.9% vs. 17.7%, P < 0.001), scoliosis (13.8% vs. 6.4%, P = 0.028), and ventricular septal defect (6.9% vs. 2.3%, P = 0.026).
Conclusions:
Multiple medical and CM-specific comorbidities were associated with reoperation. Addressing them, where possible, may aid in improving CM surgery outcomes.
Subject
Neurology (clinical),Surgery
|
|